Medical guideline

首页肿瘤学指南检索结果

检索结果

按发表年份

共搜索到131条与AI有关的结果

The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：其他 | 腹膜肿瘤

Japan Society of Gynecologic Oncology

The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely (1) Overview of the Guidelines (2) Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Recurrent Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (4) Borderline Epithelial Tumors of the Ovary (5) Malignant Germ Cell Tumors of the Ovary and (6) Malignant Sex Cord-stromal Tumors. Furthermore the Guidelines Comprise 5 Algorithms-namely (1) Initial Treatment for Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (2) Treatment for Recurrent Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Initial Treatment for Borderline Epithelial Ovarian Tumor (4) Treatment for Malignant Germ Cell Tumor and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer" (2) Involvement of Patients and General (male/female) Participants in Addition to Physicians Pharmacists and Nurses (3) Clinical Questions (CQs) in the PICO Format (4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System (5) Introduction of the Idea of a Body of Evidence (6) Categorization of References According to Research Design (7) Performance of Systematic Reviews and Meta-analysis for Three CQs and (8) Voting for Each CQ/recommendation and Description of the Consensus.
指南简介 原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma

2021年发布于 Current Oncology 28卷第2期 所属人体系统：其他 | 腹膜肿瘤

Ontario Health (Cancer Care Ontario)

Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II III Or IV Epithelial Ovary Fallopian Tube Or Primary Peritoneal Carcinoma Including All Histological Types. Methods: Consistent with the Program in Evidence-based Program's Standardized Approach MEDLINE EMBASE PubMed Cochrane Library and PROSPERO (the International Prospective Register of Systematic Reviews) Databases and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers. Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy We Recommended Olaparib (Recommendation) Niraparib (Weak Recommendation) Veliparib (Weak Recommendation) and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available the Recommendations Will Be Updated as Soon as Possible.
指南简介 原文链接
Lenalidomide Maintenance Treatment after an Autologous Stem Cell Transplant for Newly Diagnosed Multiple Myeloma

2021年发布于 National Institute for Health and Care Excellence 卷第期 所属人体系统：循环 | 骨髓瘤

National Institute for Health and Care Excellence

Multiple Myeloma treatment Lenalidomide Maintenance
指南简介 原文链接
How to Perform Leukapheresis for Procurement of the Staring Material Used for Commercial CAR T-cell Manufacturing: a Consensus from Experts Convened by the SFGM-TC

2021年发布于 Bull Cancer 108卷第3期 所属人体系统：其他 | 治疗方案

Francophone Society of Marrow Transplant and Cellular Therapy

B-cell Acute Lymphoblastic Leukemia CAR T-cells Cytapheresis Cytaphérèse Diffuse Large B-cell Lymphoma Leucémie Aiguë Lymphoblastique B Lymphome Diffus À Grandes Cellules B.
指南简介 原文链接
Interdisciplinary S2k Guidelines on the Diagnosis and Treatment of Vaginal Carcinoma and Its Precursors-recommendations on Surgical Pathology for Histopathological Workup, Diagnostics, and Reporting

2021年发布于 Pathologe 42卷第1期 所属人体系统：生殖 | 阴道肿瘤

无

Cancer Diagnostic Guidelines Histopathology Prognosis Staging Treatment VaIN Vagina WHO Workup
指南简介 原文链接
The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：生殖 | 输卵管癌

Japan Society of Gynecologic Oncology

The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely (1) Overview of the Guidelines (2) Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Recurrent Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (4) Borderline Epithelial Tumors of the Ovary (5) Malignant Germ Cell Tumors of the Ovary and (6) Malignant Sex Cord-stromal Tumors. Furthermore the Guidelines Comprise 5 Algorithms-namely (1) Initial Treatment for Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (2) Treatment for Recurrent Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Initial Treatment for Borderline Epithelial Ovarian Tumor (4) Treatment for Malignant Germ Cell Tumor and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer" (2) Involvement of Patients and General (male/female) Participants in Addition to Physicians Pharmacists and Nurses (3) Clinical Questions (CQs) in the PICO Format (4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System (5) Introduction of the Idea of a Body of Evidence (6) Categorization of References According to Research Design (7) Performance of Systematic Reviews and Meta-analysis for Three CQs and (8) Voting for Each CQ/recommendation and Description of the Consensus.
指南简介 原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 输卵管癌

Ontario Health (Cancer Care Ontario)

Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II III Or IV Epithelial Ovary Fallopian Tube Or Primary Peritoneal Carcinoma Including All Histological Types. Methods: Consistent with the Program in Evidence-based Program's Standardized Approach MEDLINE EMBASE PubMed Cochrane Library and PROSPERO (the International Prospective Register of Systematic Reviews) Databases and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers. Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy We Recommended Olaparib (Recommendation) Niraparib (Weak Recommendation) Veliparib (Weak Recommendation) and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available the Recommendations Will Be Updated as Soon as Possible.
指南简介 原文链接
Cancer in People with HIV

2021年发布于 National Comprehensive Cancer Network 卷第期 所属人体系统：其他 | 癌症患者其他类问题管理

National Comprehensive Cancer Network

Cancer HIV AIDS-Defining Malignancy Non-AIDS-Defining Malignancy
指南简介 原文链接
Hairy Cell Leukemia

2021年发布于 National Comprehensive Cancer Network 卷第期 所属人体系统：循环 | 白血病

National Comprehensive Cancer Network

Hairy Cell Leukemia diagnosis treatment supportive Care relapsed Therapy genetic Testing
指南简介 原文链接
P05.02 International Delphi Consensus on Radical Thoracic Re-Irradiation for Non-Small Cell Lung Cancer (NSCLC)

2021年发布于 Journal of Thoracic Oncology 16卷第3期 所属人体系统：呼吸 | 肺癌

无

Radiotherapy Re-irradiation Dose Constraints
指南简介 原文链接
GOECP/SEOR Radiotherapy Guidelines for Small-cell Lung Cancer

2021年发布于 World J Clin Oncol 12卷第3期 所属人体系统：呼吸 | 肺癌

Oncologic Group for the Study of Lung Cancer Spanish Society of Radiation Oncology

Brain Metastases Chemotherapy Hyperfractionated Radiation Therapy Prophylactic Brain Irradiation Reirradiation Small Cell Lung Cancer.
指南简介 原文链接
Clinical Practice Guideline for Brain Metastases of Lung Cancer in China (2021 Version)

2021年发布于 Zhonghua Zhong Liu Za Zhi 43卷第3期 所属人体系统：呼吸 | 肺癌

Chinese Association for Clinical Oncologists Medical Oncology Branch of Chinese International Exchange and Promotion Association for Medical and Healthcare

Brain Metastases Lung Neoplasms Standard Therapy.
指南简介 原文链接
Guidelines in the Management of CNS Tumors

2021年发布于 Journal of Neuro-Oncology 151卷第3期 所属人体系统：神经 | 中枢神经系统肿瘤

Joint Section on Tumors of the Congress of Neurological Surgeons and the American Association of Neurological Surgeons.

Brain Tumor Gliomas Metastatic Brain Cancer Neuro-oncology Nonfunctioning Pituitary Adenomas Vestibular Schwannomas
指南简介 原文链接
The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：生殖 | 卵巢肿瘤

Japan Society of Gynecologic Oncology

The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely (1) Overview of the Guidelines (2) Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Recurrent Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (4) Borderline Epithelial Tumors of the Ovary (5) Malignant Germ Cell Tumors of the Ovary and (6) Malignant Sex Cord-stromal Tumors. Furthermore the Guidelines Comprise 5 Algorithms-namely (1) Initial Treatment for Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (2) Treatment for Recurrent Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Initial Treatment for Borderline Epithelial Ovarian Tumor (4) Treatment for Malignant Germ Cell Tumor and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer" (2) Involvement of Patients and General (male/female) Participants in Addition to Physicians Pharmacists and Nurses (3) Clinical Questions (CQs) in the PICO Format (4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System (5) Introduction of the Idea of a Body of Evidence (6) Categorization of References According to Research Design (7) Performance of Systematic Reviews and Meta-analysis for Three CQs and (8) Voting for Each CQ/recommendation and Description of the Consensus.
指南简介 原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 卵巢肿瘤

Ontario Health (Cancer Care Ontario)

Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II III Or IV Epithelial Ovary Fallopian Tube Or Primary Peritoneal Carcinoma Including All Histological Types. Methods: Consistent with the Program in Evidence-based Program's Standardized Approach MEDLINE EMBASE PubMed Cochrane Library and PROSPERO (the International Prospective Register of Systematic Reviews) Databases and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers. Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy We Recommended Olaparib (Recommendation) Niraparib (Weak Recommendation) Veliparib (Weak Recommendation) and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available the Recommendations Will Be Updated as Soon as Possible.
指南简介 原文链接
Hong Kong Urological Association-Hong Kong Society of Uro-Oncology Consensus Statements on the Management of Advanced Prostate Cancer-2019 Updates

2021年发布于 Asia Pac J Clin Oncol 17卷第Suppl 3期 所属人体系统：生殖 | 前列腺肿瘤

Hong Kong Urological Association-Hong Kong Society of Uro-Oncology

Hong Kong Castration-naïve Prostate Cancer Castration-resistant Prostate Cancer Consensus Metastatic Prostate Cancer
指南简介 原文链接
Management of Melanoma Brain Metastases: Evidence-based Clinical Practice Guidelines by Cancer Council Australia

2021年发布于 European Journal of Cancer 142卷第期 所属人体系统：其他 | 黑色素瘤

Cancer Council Australia

Guidelines Melanoma Brain Metastasis Radiation Therapy Surgery Systemic Therapy
指南简介 原文链接
Localized Prostate Cancer in Candidates for Renal Transplantation and Recipients of a Kidney Transplant: the French Guidelines from CTAFU

2021年发布于 Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 31卷第1期 所属人体系统：生殖 | 前列腺肿瘤

Du Comité De Transplantation De L’Association Française D’urologie

Cancer De La Prostate Kidney Transplantation Prostate Cancer Transplantation Rénale Waiting List.
指南简介 原文链接
Delphi Consensus on Strategies in the Management of Opioid-induced Constipation in Cancer Patients

2021年发布于 Bmc Palliative Care 20卷第1期 所属人体系统：其他 | 症状管理

无

Cancer Constipation Laxative Opioid Pain.
指南简介 原文链接
Neurological and Vascular Complications of Primary and Secondary Brain Tumours: EANO-ESMO Clinical Practice Guidelines for Prophylaxis, Diagnosis, Treatment and Follow-up

2021年发布于 Ann Oncol 32卷第2期 所属人体系统：其他 | 症状管理

European Association of Neuro-Oncology European Society for Medical Oncology

Brain Metastasis Brain Tumour Complications Oedema Seizures Thrombosis
指南简介 原文链接

人体系统

共搜索到131条 与AI有关的结果

2021年 发布于 Journal of Gynecologic Oncology 32卷 第2期 所属人体系统： 其他 | 腹膜肿瘤

Japan Society of Gynecologic Oncology

2021年 发布于 Current Oncology 28卷 第2期 所属人体系统： 其他 | 腹膜肿瘤

Ontario Health (Cancer Care Ontario)

2021年 发布于 National Institute for Health and Care Excellence 卷 第期 所属人体系统： 循环 | 骨髓瘤

National Institute for Health and Care Excellence

2021年 发布于 Bull Cancer 108卷 第3期 所属人体系统： 其他 | 治疗方案

Francophone Society of Marrow Transplant and Cellular Therapy

2021年 发布于 Pathologe 42卷 第1期 所属人体系统： 生殖 | 阴道肿瘤

无

2021年 发布于 Journal of Gynecologic Oncology 32卷 第2期 所属人体系统： 生殖 | 输卵管癌

Japan Society of Gynecologic Oncology

2021年 发布于 Current Oncology 28卷 第2期 所属人体系统： 生殖 | 输卵管癌

Ontario Health (Cancer Care Ontario)

2021年 发布于 National Comprehensive Cancer Network 卷 第期 所属人体系统： 其他 | 癌症患者其他类问题管理

National Comprehensive Cancer Network

2021年 发布于 National Comprehensive Cancer Network 卷 第期 所属人体系统： 循环 | 白血病

National Comprehensive Cancer Network

2021年 发布于 Journal of Thoracic Oncology 16卷 第3期 所属人体系统： 呼吸 | 肺癌

无

2021年 发布于 World J Clin Oncol 12卷 第3期 所属人体系统： 呼吸 | 肺癌

Oncologic Group for the Study of Lung Cancer Spanish Society of Radiation Oncology

2021年 发布于 Zhonghua Zhong Liu Za Zhi 43卷 第3期 所属人体系统： 呼吸 | 肺癌

Chinese Association for Clinical Oncologists Medical Oncology Branch of Chinese International Exchange and Promotion Association for Medical and Healthcare

2021年 发布于 Journal of Neuro-Oncology 151卷 第3期 所属人体系统： 神经 | 中枢神经系统肿瘤

Joint Section on Tumors of the Congress of Neurological Surgeons and the American Association of Neurological Surgeons.

2021年 发布于 Journal of Gynecologic Oncology 32卷 第2期 所属人体系统： 生殖 | 卵巢肿瘤

Japan Society of Gynecologic Oncology

2021年 发布于 Current Oncology 28卷 第2期 所属人体系统： 生殖 | 卵巢肿瘤

Ontario Health (Cancer Care Ontario)

2021年 发布于 Asia Pac J Clin Oncol 17卷 第Suppl 3期 所属人体系统： 生殖 | 前列腺肿瘤

Hong Kong Urological Association-Hong Kong Society of Uro-Oncology

2021年 发布于 European Journal of Cancer 142卷 第期 所属人体系统： 其他 | 黑色素瘤

Cancer Council Australia

2021年 发布于 Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 31卷 第1期 所属人体系统： 生殖 | 前列腺肿瘤

Du Comité De Transplantation De L’Association Française D’urologie

2021年 发布于 Bmc Palliative Care 20卷 第1期 所属人体系统： 其他 | 症状管理

无

2021年 发布于 Ann Oncol 32卷 第2期 所属人体系统： 其他 | 症状管理

European Association of Neuro-Oncology European Society for Medical Oncology

共搜索到131条与AI有关的结果

2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：其他 | 腹膜肿瘤

2021年发布于 Current Oncology 28卷第2期 所属人体系统：其他 | 腹膜肿瘤

2021年发布于 National Institute for Health and Care Excellence 卷第期 所属人体系统：循环 | 骨髓瘤

2021年发布于 Bull Cancer 108卷第3期 所属人体系统：其他 | 治疗方案

2021年发布于 Pathologe 42卷第1期 所属人体系统：生殖 | 阴道肿瘤

2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：生殖 | 输卵管癌

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 输卵管癌

2021年发布于 National Comprehensive Cancer Network 卷第期 所属人体系统：其他 | 癌症患者其他类问题管理

2021年发布于 National Comprehensive Cancer Network 卷第期 所属人体系统：循环 | 白血病

2021年发布于 Journal of Thoracic Oncology 16卷第3期 所属人体系统：呼吸 | 肺癌

2021年发布于 World J Clin Oncol 12卷第3期 所属人体系统：呼吸 | 肺癌

2021年发布于 Zhonghua Zhong Liu Za Zhi 43卷第3期 所属人体系统：呼吸 | 肺癌

2021年发布于 Journal of Neuro-Oncology 151卷第3期 所属人体系统：神经 | 中枢神经系统肿瘤

2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：生殖 | 卵巢肿瘤

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 卵巢肿瘤

2021年发布于 Asia Pac J Clin Oncol 17卷第Suppl 3期 所属人体系统：生殖 | 前列腺肿瘤

2021年发布于 European Journal of Cancer 142卷第期 所属人体系统：其他 | 黑色素瘤

2021年发布于 Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 31卷第1期 所属人体系统：生殖 | 前列腺肿瘤

2021年发布于 Bmc Palliative Care 20卷第1期 所属人体系统：其他 | 症状管理

2021年发布于 Ann Oncol 32卷第2期 所属人体系统：其他 | 症状管理